HK1087007A1 - Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum- glucose-lowering and serum-lipid-lowering activity - Google Patents

Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum- glucose-lowering and serum-lipid-lowering activity

Info

Publication number
HK1087007A1
HK1087007A1 HK06107039.2A HK06107039A HK1087007A1 HK 1087007 A1 HK1087007 A1 HK 1087007A1 HK 06107039 A HK06107039 A HK 06107039A HK 1087007 A1 HK1087007 A1 HK 1087007A1
Authority
HK
Hong Kong
Prior art keywords
serum
lowering
phenylthiocarboxylic
lipid
glucose
Prior art date
Application number
HK06107039.2A
Other languages
English (en)
Inventor
Giannessi F Fabio
Tassoni E Emanuela
Ornella Tinti M O Maria
Pessotto P Pompeo
Dell Uomo N Natalina
Floriana Sciarroni A F Anna
Brunetti T Tiziana
Maria Milazzo F M Ferdinando
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1087007A1 publication Critical patent/HK1087007A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/134—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings monocyclic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
HK06107039.2A 2002-12-19 2006-06-21 Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum- glucose-lowering and serum-lipid-lowering activity HK1087007A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000629A ITRM20020629A1 (it) 2002-12-19 2002-12-19 Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
PCT/IT2003/000820 WO2004056355A1 (en) 2002-12-19 2003-12-16 USE OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXYCARBOXYLIC ACIDS WITH SERUM-GLUCOSE-LOWERING AND SERUM-LIPID-LOWERING ACTIVITY

Publications (1)

Publication Number Publication Date
HK1087007A1 true HK1087007A1 (en) 2006-10-06

Family

ID=32676886

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06107039.2A HK1087007A1 (en) 2002-12-19 2006-06-21 Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum- glucose-lowering and serum-lipid-lowering activity

Country Status (21)

Country Link
US (1) US7375124B2 (xx)
EP (1) EP1572180B1 (xx)
JP (1) JP2006512362A (xx)
KR (1) KR20050085222A (xx)
CN (1) CN100393309C (xx)
AR (1) AR042547A1 (xx)
AT (1) ATE423558T1 (xx)
AU (1) AU2003288546B8 (xx)
BR (1) BR0317359A (xx)
CA (1) CA2506627A1 (xx)
DE (1) DE60326382D1 (xx)
DK (1) DK1572180T3 (xx)
ES (1) ES2321708T3 (xx)
HK (1) HK1087007A1 (xx)
IT (1) ITRM20020629A1 (xx)
MX (1) MXPA05005848A (xx)
PL (1) PL378414A1 (xx)
PT (1) PT1572180E (xx)
SI (1) SI1572180T1 (xx)
TW (1) TWI308564B (xx)
WO (1) WO2004056355A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006045010A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
CA2676984C (en) 2007-02-01 2015-03-17 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
US8114995B2 (en) 2008-06-26 2012-02-14 Resverlogix Corp. Methods of preparing quinazolinone derivatives
BRPI0919327A2 (pt) * 2008-09-05 2019-09-24 Acucela Inc compostos ligados a enxofre para tratar doenças e distúrbios oftálmicos
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
JP5795304B2 (ja) 2009-03-18 2015-10-14 レスバーロジックス コーポレイション 新規抗炎症剤
KR101892987B1 (ko) 2009-04-22 2018-08-30 리스버로직스 코퍼레이션 신규한 소염제
CA2851996C (en) 2011-11-01 2020-01-07 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
EP2935253B1 (en) 2012-12-21 2018-08-01 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
CA2977308A1 (en) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
CN114901641A (zh) * 2020-02-28 2022-08-12 四川科伦博泰生物医药股份有限公司 芳香族化合物及其药物组合物和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
GB1121722A (en) * 1966-03-31 1968-07-31 Ici Ltd New carboxylic acid derivatives
GB1422679A (en) * 1972-11-16 1976-01-28 Funai Pharmaceutical Ind Ltd Substituted phenoxy-a-methylpropionic acid derivatives and a process for producing the same
FR2285867A1 (fr) * 1974-09-30 1976-04-23 Lafon Labor Derives du diphenylsulfoxyde
ITRM20020014A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del

Also Published As

Publication number Publication date
CN100393309C (zh) 2008-06-11
EP1572180B1 (en) 2009-02-25
BR0317359A (pt) 2005-11-08
CN1728992A (zh) 2006-02-01
US20060154979A1 (en) 2006-07-13
WO2004056355A1 (en) 2004-07-08
PL378414A1 (pl) 2006-04-03
TWI308564B (en) 2009-04-11
US7375124B2 (en) 2008-05-20
TW200420531A (en) 2004-10-16
MXPA05005848A (es) 2005-08-26
AU2003288546B2 (en) 2009-04-30
PT1572180E (pt) 2009-05-04
DE60326382D1 (de) 2009-04-09
SI1572180T1 (sl) 2009-06-30
AU2003288546B8 (en) 2009-06-11
EP1572180A1 (en) 2005-09-14
ITRM20020629A1 (it) 2004-06-20
AR042547A1 (es) 2005-06-22
KR20050085222A (ko) 2005-08-29
DK1572180T3 (da) 2009-06-02
AU2003288546A1 (en) 2004-07-14
ATE423558T1 (de) 2009-03-15
JP2006512362A (ja) 2006-04-13
CA2506627A1 (en) 2004-07-08
ES2321708T3 (es) 2009-06-10

Similar Documents

Publication Publication Date Title
HK1087007A1 (en) Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum- glucose-lowering and serum-lipid-lowering activity
AU2003288902A8 (en) Microcapsules and methods of use
IL171501A (en) Genetically engineered cutaneous microorganisms and their use
HK1079789A1 (zh) 血管靜態毒性試劑及其使用方法
EP1465615A4 (en) TRICYCLIC BISENONE DERIVATIVES AND METHODS OF USE
EP1474445A4 (en) ADIPONECTIN GLYCO-ISOFORMS, AND USES THEREOF
IL201111A0 (en) Ester compound and medical use thereof
PT2702871T (pt) Biotecido de colagénio e sua utilização
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
AU2003214945A8 (en) Multi-function catheter and use thereof
AU2002360400A8 (en) Construction and use of micro-electrode arrays
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
HK1078088A1 (en) Substituted phenylacetamides and their use as glucokinase activators
AU2002310008A1 (en) Composition with enhance cetylpyridinium chloride activity and method of using the same
EP1551384A4 (en) R-NSAID ESTERS AND ITS USE
EP1476150A4 (en) CARBOXY FULLERES AND USE METHOD THEREFOR
AU2003301883A8 (en) Modified luciferase nucleic acids and methods of use
AU2003298020A8 (en) Catalytic antioxidants and methods of use
GB0212405D0 (en) Composition and its therapeutic use
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
EP1545287A4 (en) VASOREGULATORY COMPOUNDS AND METHODS RELATING TO THEIR USE
AU2003287802A1 (en) Palpometer and methods of use thereof
EP1601348A4 (en) Compositions and methods with improved therapeutic activity
AU2003285686A8 (en) Glycoisoforms of adiponectin and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121216